TruDiagnosis®
Akonni Biosystems has developed a powerful, near-point-of-care molecular testing platform, called TruDiagnosis, which utilizes revolutionary and proprietary on-slide PCR and gel-drop microarray technology. The platform offers the ability to analyze dozens of targets in one rapid, self-contained, easy-to-use and low-cost test. The platform is applicable to a broad range of diagnostics as it provides a substantially more scalable solution than other molecular-based methods and provides superior results at a lower overall cost.